首页 | 本学科首页   官方微博 | 高级检索  
     


One-year experience with intravenous treprostinil for pulmonary arterial hypertension
Authors:Raymond L. Benza  Victor F. Tapson  Mardi Gomberg-Maitland  Abigail Poms  Robyn J. Barst  Vallerie V. McLaughlin
Affiliation:1. Division of Cardiovascular Diseases, Allegheny General Hospital, Pittsburgh, Pennsylvania;2. Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina;3. Section of Cardiology, University of Chicago, Chicago, Illinois;4. Barst Consulting, New York, New York;5. Division of Cardiovascular Medicine, University of Michigan Health System, Ann Arbor, Michigan;1. Department of Cardiology, Children’s Hospital Boston, Boston, Mass;2. Department of Cardiovascular Surgery, Children’s Hospital Boston, Boston, Mass;3. Department of Anesthesia, Children’s Hospital Boston, Boston, Mass;4. Department of Pediatrics, Harvard Medical School, Boston, Mass;5. Department of Surgery, Harvard Medical School, Boston, Mass;6. Department of Anesthesia, Harvard Medical School, Boston, Mass;1. Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;2. Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland;1. Surgical Research Laboratory, INSERM U999, Marie Lannelongue Hospital, Le plessis Robinson, France;2. Department of Intensive Care Medicine, Foch Hospital, Suresnes, France;3. Department of Thoracic Surgery, Foch Hospital, Suresnes, France;4. Department of Anaesthesiology and Operative Intensive Care Medicine, Medical Center Cologne-Merheim, University of Witten/Herdecke, Cologne, Germany
Abstract:
Keywords:treprostinil  prostacyclin  pulmonary arterial hypertension
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号